Abstract: An embodiment provides a phosphor composition and a light emitting device package comprising the same, wherein the phosphor composition comprises green phosphor, amber phosphor, and red phosphor, wherein the amber phosphor is expressed as chemical formula Lim?2XSi12?m?nAlm+nOnN16?n:Eu2+, where 2?m?5, 2?n?10, 0.01?X?1. The light emitting element package of the embodiment can display white light having improved brightness and color rendering index.

Abstract: The present invention relates to a pharmaceutical composition comprising a compound of formula (1), (2) or (3) as defined in the specification for the prevention or treatment of diseases associated with oxidative stress, mitochondria dysfunction, hypoxic injury, necrosis and/or ischemic reperfusion injury, and a cosmetic composition comprising an indole compound having an antioxidant effect.

Abstract: An information providing method which is implementable by using an ultrasound apparatus includes obtaining ultrasound image data which relates to an object; displaying, on a first area of a screen, a gain setup window for setting a gain of the obtained ultrasound image data; receiving a gain which is set by a user on the gain setup window; and displaying, on a second area of the screen, an ultrasound image of the object to which the set gain is applied.

Abstract: An embodiment relates to a light emitting device package and a lighting apparatus having the same. According to the embodiment, a light emitting device package includes a first lead frame; a second lead frame spaced apart from the first lead frame; a body coupled to the first lead frame and the second lead frame and includes a first cavity which exposes a portion of the upper surface of the first lead frame, a second cavity which exposes a portion of the upper surface of the second lead frame, and a spacer which is disposed between the first lead frame and the second frame; at least one light emitting device disposed in the first cavity; and a protection device disposed in the second cavity. The second cavity is disposed on a first inside surface of the first cavity and the first inside surface is connected to an upper surface of the spacer, and an area of a bottom surface of the first cavity is equal to or less than 40% of entire area of the body.

Abstract: Provided is an ultrasound imaging apparatus including a probe configured to transmit an ultrasound signal to an object along a first path and receive an echo signal reflected from the object; and a processor configured to generate a first ultrasound image representing the object, detect at least one region having low image quality among regions in the generated first ultrasound image according to a predetermined criterion, control the ultrasound signal to be transmitted along a second path by focusing the ultrasound signal at a focal point within a predetermined region of the object corresponding to the detected at least one region, and generate a second ultrasound image representing the object based on an echo signal received in response to the ultrasound signal transmitted to the object along the second path.

Abstract: Disclosed herein are a medical imaging apparatus and a method of providing medical images which may more accurately quantify elasticity of tissues. The medical imaging apparatus includes a display unit displaying an elastic image in which different colors are mapped according to strain values of tissues within an object, and a controller, when a target area containing lesion tissues and a reference area containing normal tissues are set in the elastic image, calculating a representative target area value representing strain values of the target area and a representative reference area value representing strain values of the reference area, and displaying a color reference area, expressing distribution of the representative reference area value in the reference area in color, through the display unit.

Abstract: Disclosed are a probe control method and apparatus and an ultrasound system which apply a mounting signal used to sense a mounting status of a probe, detect the mounting signal transferred through a cable, and automatically activate/deactivate the probe according to a change in a sensed mounting status.

Abstract: Disclosed herein are an a medical imaging apparatus capable of easily detecting the location of specific tissue, for example, a lymph node, and a method of providing medical images. The medical image providing method includes: arranging and displaying n thumbnail images for n first photoacoustic images acquired by initially scanning an object, wherein n is a natural number; and enhancing a thumbnail image that is identical to a second photoacoustic image acquired by secondarily scanning the object, among the n thumbnail images.

Abstract: An embodiment provides a light-emitting device package comprising: a first lead frame; a second lead frame; a light-emitting device electrically connected to the first lead frame and the second lead frame; a molding unit arranged to surround the light-emitting device; and an oxynitride-based phosphor represented by chemical formula LXMYOaNbAcBd:zR (1?X?3, 3?Y?7, 0.001?Z?1.0, 0?a?5, 0.1?b?9, 0.001?c?0.3, 0.001?d?0.3), and the light-emitting device package of the present embodiment can implement a white color light having excellent luminance and color rendering index.

Abstract: The present invention relates to an indole amide compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.

Abstract: An embodiment relates to a light emitting device package and a lighting apparatus having the same. According to the embodiment, a light emitting device package includes a first lead frame; a second lead frame spaced apart from the first lead frame; a body coupled to the first lead frame and the second lead frame and includes a first cavity which exposes a portion of the upper surface of the first lead frame, a second cavity which exposes a portion of the upper surface of the second lead frame, and a spacer which is disposed between the first lead frame and the second frame; at least one light emitting device disposed in the first cavity; and a protection device disposed in the second cavity. The second cavity is disposed on a first inside surface of the first cavity and the first inside surface is connected to an upper surface of the spacer, and an area of a bottom surface of the first cavity is equal to or less than 40% of entire area of the body.

Abstract: A phosphor composition of an embodiment and a light emitting device package including the same includes: a green phosphor excited by blue light to emit green light; a first red phosphor of a nitride series which is excited by the blue light and emits first red light; and a second red phosphor of a fluorine series which is excited by the blue light and emits second red light, and is capable of emitting white light without deterioration of optical characteristics at a high temperature while improving luminous flux and color reproduction rate as compared with a light emitting device package including a conventional phosphor composition.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating fatty liver diseases, containing (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof as active ingredients. (Tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof, according to the present invention, can effectively inhibit fatty liver, hepatitis and hepatic fibrosis and can be useful for preventing or treating NAFLD, and in particular, NASH.

Abstract: An embodiment relates to a light emitting device package and a lighting apparatus having the same. According to the embodiment, A light emitting device package includes a first lead frame; a second lead frame spaced apart from the first lead frame; a body coupled to the first lead frame and the second lead frame and includes a first cavity which exposes a portion of the upper surface of the first lead frame, a second cavity which exposes a portion of the upper surface of the second lead frame, and a spacer which is disposed between the first lead frame and the second frame; at least one light emitting device disposed in the first cavity; and a protection device disposed in the second cavity. The second cavity is disposed on a first inside surface of the first cavity and the first inside surface is connected to an upper surface of the spacer, and an area of a bottom surface of the first cavity is equal to or less than 40% of entire area of the body.

Abstract: An embodiment provides a phosphor composition and a light emitting device package comprising the same, wherein the phosphor composition comprises green phosphor, amber phosphor, and red phosphor, wherein the amber phosphor is expressed as chemical formula Lim?2XSi12-m?nAlm+nOnN16-n:Eu2+, where 2?m?5, 2?n?10, 0.01?X?1. The light emitting element package of the embodiment can display white light having improved brightness and color rendering index.

Abstract: There are provided embodiments for providing a user interface for performing a filtering process upon a vector Doppler image. In one embodiment, by way of non-limiting example, an ultrasound system comprises: a processing unit configured to form vector information of a target object based on ultrasound data corresponding to the target object and form a user interface for performing the filtering process upon the vector Doppler image based on the vector information.

Abstract: The present invention relates to a pharmaceutical composition comprising a compound of formula (1), (2) or (3) as defined in the specification for the prevention or treatment of diseases associated with oxidative stress, mitochondria dysfunction, hypoxic injury, necrosis and/or ischemic reperfusion injury, and a cosmetic composition comprising an indole compound having an antioxidant effect

Abstract: Disclosed herein is a vehicular high pressure direct injection type injector with valve seat body for fuel-atomization. A nozzle hole has an elliptical cross-section so that the fuel injection speed can be increased, whereby a fuel atomization effect can be maximized. Furthermore, a stepped hole is formed under the nozzle hole so that the nozzle hole can be fundamentally prevented from becoming clogged with combustion byproducts.

Abstract: Provided is a direct spray fuel injector including a bundle of opening/closing valves, wherein the bundle of opening/closing valves includes: a valve needle that is disposed within a valve housing; an electromagnetic coil that is installed at a side opposite to the spray hole of the valve needle; an armature that is coaxially mounted on an outer circumferential surface of the valve needle to be slidable in an axial direction; and a pressurizing spring that is installed to pressurize the valve needle toward the spray hole and causes the valve needle to close the spray hole in normal times, and the bundle of opening closing valves is configured to pressurize the valve needle by the armature so that bounce generated when the valve needle in an open state approaches the spray hole so as to close the spray hole is able to be attenuated.

Abstract: An embodiment relates to a light emitting device package and a lighting apparatus having the same. According to the embodiment, A light emitting device package includes a first lead frame; a second lead frame spaced apart from the first lead frame; a body coupled to the first lead frame and the second lead frame and includes a first cavity which exposes a portion of the upper surface of the first lead frame, a second cavity which exposes a portion of the upper surface of the second lead frame, and a spacer which is disposed between the first lead frame and the second frame; at least one light emitting device disposed in the first cavity; and a protection device disposed in the second cavity. The second cavity is disposed on a first inside surface of the first cavity and the first inside surface is connected to an upper surface of the spacer, and an area of a bottom surface of the first cavity is equal to or less than 40% of entire area of the body.